Document Detail

Crosstalk of the heart and periphery: skeletal and cardiac muscle as therapeutic targets in heart failure.
MedLine Citation:
PMID:  9375991     Owner:  NLM     Status:  MEDLINE    
Heart failure syndrome is initiated as the body's metabolic needs temporarily exceed the pumping capacity of the heart. In most cases, this phenomenon tends to occur during physical exercise. Although not always subjectively recognized, limited exercise capacity remains the clinical hallmark of congestive heart failure. It can be measured objectively as reduced skeletal muscle performance and maximal whole-body oxygen uptake, which are not necessarily explained by central haemodynamic abnormalities. In fact, the initial cardiac condition sets forth a series of peripheral adaptations that are potentially life-saving during acute decompensation but become disadvantageous and symptom-generating in stable heart failure. Inodilator drugs were theoretically ideal to revert the adverse haemodynamic crosstalk between the heart and periphery. However, these drugs failed to improve prognosis in congestive heart failure, whereas drugs that did so showed typically unimpressive haemodynamic effects. Exercise therapy has recently emerged as a safe and effective way to enhance physical performance and subjective well-being in congestive heart failure. A dual therapeutic approach is suggested, consisting of exercise training to improve the periphery and the use of cardioprotective drugs to limit cardiac cellular damage from neurohormonal activation.
A Gordon; L M Voipio-Pulkki
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Annals of medicine     Volume:  29     ISSN:  0785-3890     ISO Abbreviation:  Ann. Med.     Publication Date:  1997 Aug 
Date Detail:
Created Date:  1997-12-11     Completed Date:  1997-12-11     Revised Date:  2013-05-28    
Medline Journal Info:
Nlm Unique ID:  8906388     Medline TA:  Ann Med     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  327-31     Citation Subset:  IM    
Department of Cardiology, Karolinska Institute, Huddinge Hospital, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / therapeutic use
Carbazoles / therapeutic use
Cardiac Output
Cardiotonic Agents / therapeutic use
Exercise Therapy
Heart / physiology*
Heart Failure / drug therapy,  physiopathology*,  therapy*
Muscle, Skeletal / physiopathology*
Muscle, Smooth / physiology*
Propanolamines / therapeutic use
Vasodilator Agents / therapeutic use
Ventricular Function, Left
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Carbazoles; 0/Cardiotonic Agents; 0/Propanolamines; 0/Vasodilator Agents; 0K47UL67F2/carvedilol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Heart rate dynamics and vulnerability to ventricular tachyarrhythmias.
Next Document:  Metabolic responses of extracellular matrix in tissue repair.